Always verify your vial strength, dilution amount, and prescription instructions
Alternative approach (more economical): Start your first 8 weeks with a 5mg vial instead
Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine , 2021;384:9891002
Jessie Cheung, M.D., is a board-certified dermatologist specializing in dermatological, surgical, and cosmetic procedures based in Willowbrook, IL
GLP-1 RAs STEP 1 (2021) : Semaglutide 2.4 ./ 14.9% 68 2.4% (Wilding et al., 2021, NEJM) SURMOUNT-1 (2022) : Tirzepatide (GLP-1/GIP dual agonist) 15 ./ 20.9% (Jastreboff et al., 2022, NEJM) GLP-1 HbA1c () 2 (Hypoglycemia) Glucose-dependent LEADER (liraglutide) SUSTAIN-6 (semaglutide) 2024 FDA Semaglutide (Wegovy) FLOW (2024) semaglutide (MASLD/NAFLD) GLP-1 RAs GLP-1
Ozempic arguably has the most name recognition, but it isnt the only GLP-1 agonist